The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders

Derek K. Smith, Miao He, Chun Li Zhang, Jialin C Zheng

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Neural cell identity reprogramming strategies aim to treat age-related neurodegenerative disorders with newly induced neurons that regenerate neural architecture and functional circuits in vivo. The isolation and neural differentiation of pluripotent embryonic stem cells provided the first in vitro models of human neurodegenerative disease. Investigation into the molecular mechanisms underlying stem cell pluripotency revealed that somatic cells could be reprogrammed to induced pluripotent stem cells (iPSCs) and these cells could be used to model Alzheimer disease, amyotrophic lateral sclerosis, Huntington disease, and Parkinson disease. Additional neural precursor and direct transdifferentiation strategies further enabled the induction of diverse neural linages and neuron subtypes both in vitro and in vivo. In this review, we highlight neural induction strategies that utilize stem cells, iPSCs, and lineage reprogramming to model or treat age-related neurodegenerative diseases, as well as, the clinical challenges related to neural transplantation and in vivo reprogramming strategies.

Original languageEnglish (US)
JournalProgress in Neurobiology
DOIs
StateAccepted/In press - Sep 11 2015

Fingerprint

Neurodegenerative Diseases
Induced Pluripotent Stem Cells
Stem Cells
Neurons
Pluripotent Stem Cells
Huntington Disease
Amyotrophic Lateral Sclerosis
Cell Lineage
Embryonic Stem Cells
Parkinson Disease
Alzheimer Disease
Therapeutics
Transplantation
Cellular Reprogramming
In Vitro Techniques

Keywords

  • Alzheimer disease
  • Amyotrophic lateral sclerosis
  • Cell identity
  • Embryonic stem cell
  • Huntington disease
  • In vivo reprogramming
  • Induced neural stem cell
  • Induced pluripotent stem cell
  • Neural stem cell
  • Neurodegeneration
  • Neuron
  • Parkinson disease
  • Regenerative medicine
  • Reprogramming
  • Stem cell
  • Transdifferentiation

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders. / Smith, Derek K.; He, Miao; Zhang, Chun Li; Zheng, Jialin C.

In: Progress in Neurobiology, 11.09.2015.

Research output: Contribution to journalArticle

@article{5747ff96e72b4a7b882b0bd2c0f4e071,
title = "The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders",
abstract = "Neural cell identity reprogramming strategies aim to treat age-related neurodegenerative disorders with newly induced neurons that regenerate neural architecture and functional circuits in vivo. The isolation and neural differentiation of pluripotent embryonic stem cells provided the first in vitro models of human neurodegenerative disease. Investigation into the molecular mechanisms underlying stem cell pluripotency revealed that somatic cells could be reprogrammed to induced pluripotent stem cells (iPSCs) and these cells could be used to model Alzheimer disease, amyotrophic lateral sclerosis, Huntington disease, and Parkinson disease. Additional neural precursor and direct transdifferentiation strategies further enabled the induction of diverse neural linages and neuron subtypes both in vitro and in vivo. In this review, we highlight neural induction strategies that utilize stem cells, iPSCs, and lineage reprogramming to model or treat age-related neurodegenerative diseases, as well as, the clinical challenges related to neural transplantation and in vivo reprogramming strategies.",
keywords = "Alzheimer disease, Amyotrophic lateral sclerosis, Cell identity, Embryonic stem cell, Huntington disease, In vivo reprogramming, Induced neural stem cell, Induced pluripotent stem cell, Neural stem cell, Neurodegeneration, Neuron, Parkinson disease, Regenerative medicine, Reprogramming, Stem cell, Transdifferentiation",
author = "Smith, {Derek K.} and Miao He and Zhang, {Chun Li} and Zheng, {Jialin C}",
year = "2015",
month = "9",
day = "11",
doi = "10.1016/j.pneurobio.2016.01.006",
language = "English (US)",
journal = "Progress in Neurobiology",
issn = "0301-0082",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders

AU - Smith, Derek K.

AU - He, Miao

AU - Zhang, Chun Li

AU - Zheng, Jialin C

PY - 2015/9/11

Y1 - 2015/9/11

N2 - Neural cell identity reprogramming strategies aim to treat age-related neurodegenerative disorders with newly induced neurons that regenerate neural architecture and functional circuits in vivo. The isolation and neural differentiation of pluripotent embryonic stem cells provided the first in vitro models of human neurodegenerative disease. Investigation into the molecular mechanisms underlying stem cell pluripotency revealed that somatic cells could be reprogrammed to induced pluripotent stem cells (iPSCs) and these cells could be used to model Alzheimer disease, amyotrophic lateral sclerosis, Huntington disease, and Parkinson disease. Additional neural precursor and direct transdifferentiation strategies further enabled the induction of diverse neural linages and neuron subtypes both in vitro and in vivo. In this review, we highlight neural induction strategies that utilize stem cells, iPSCs, and lineage reprogramming to model or treat age-related neurodegenerative diseases, as well as, the clinical challenges related to neural transplantation and in vivo reprogramming strategies.

AB - Neural cell identity reprogramming strategies aim to treat age-related neurodegenerative disorders with newly induced neurons that regenerate neural architecture and functional circuits in vivo. The isolation and neural differentiation of pluripotent embryonic stem cells provided the first in vitro models of human neurodegenerative disease. Investigation into the molecular mechanisms underlying stem cell pluripotency revealed that somatic cells could be reprogrammed to induced pluripotent stem cells (iPSCs) and these cells could be used to model Alzheimer disease, amyotrophic lateral sclerosis, Huntington disease, and Parkinson disease. Additional neural precursor and direct transdifferentiation strategies further enabled the induction of diverse neural linages and neuron subtypes both in vitro and in vivo. In this review, we highlight neural induction strategies that utilize stem cells, iPSCs, and lineage reprogramming to model or treat age-related neurodegenerative diseases, as well as, the clinical challenges related to neural transplantation and in vivo reprogramming strategies.

KW - Alzheimer disease

KW - Amyotrophic lateral sclerosis

KW - Cell identity

KW - Embryonic stem cell

KW - Huntington disease

KW - In vivo reprogramming

KW - Induced neural stem cell

KW - Induced pluripotent stem cell

KW - Neural stem cell

KW - Neurodegeneration

KW - Neuron

KW - Parkinson disease

KW - Regenerative medicine

KW - Reprogramming

KW - Stem cell

KW - Transdifferentiation

UR - http://www.scopus.com/inward/record.url?scp=84958555048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958555048&partnerID=8YFLogxK

U2 - 10.1016/j.pneurobio.2016.01.006

DO - 10.1016/j.pneurobio.2016.01.006

M3 - Article

JO - Progress in Neurobiology

JF - Progress in Neurobiology

SN - 0301-0082

ER -